Table 1.
SNP analysed |
Results | Study group | Disease | Age of studied population | Country | Authors |
---|---|---|---|---|---|---|
TLR4
rs4986791
TLR4 rs4986790 |
no association | 185 IMD 770 HC |
IMD MM |
Adults and children | Austria | Biebl et al. [34] |
TLR4 rs4986790 | no association | 1047 IMD 879 BD |
IMD | Adults and children | UK | Read et al. [33] |
TLR 9
rs352140
TLR 9 rs5743836 |
TLR9 rs5743836—ProMM p < 0.01 | 390 MM | MM | Children | Netherlands | Sanders et al. [37] |
TLR4 rs4986790 |
TLR4
rs4986790 - ProIMD
p = 0.007 in children younger than 12 months |
197 IMD 214 HC |
IMD | Adults and children | Germany | Faber et al. [30] |
TIRAP rs8177374 NFKBIA rs3138053 NFKBIA rs2233406 NFKBIE rs529948 NFKBIZ rs6165997 TONSL rs760477 PTPN22 rs2476601 |
NFKBIE rs529948 SuPM p < 0.0001 all SNPs —no association in MM |
372 PM 907 PB 1273HC 406 MM 272 HC |
PM MM |
children | Denmark | Lunbdo et al. [39] |
NFKBIL2 rs760477 NFKBIL2 rs2306384 NFKBIL2 rs4082353 NFKBIL2 rs4925858 NFKBIL2 rs10448143 NFKBIL2 rs2170096 NFKBIL2 rs2272658 NFKBIL2 rs135258200 NFKBIL2 rs4380978 | NFKBIL2 rs760477 SuIPD p = 0.0006 NFKBIL2 rs4925858 SuIPD p = 0.003 remaining SNPs —no association | UK 275 patients 733 HC Kenya 687 patients 173 PB 550 HC |
IPD | Adults Children |
UK Kenya |
Chapman et al. [40] |
TLR2 rs5743708 TLR2 rs5743708 TLR4 rs4986790 |
TLR4 rs4986790 SuIMD p = 0.0472 TLR 2 rs5743708 SuIMD p = 0.0003 TLR 2 rs5743708 SuIPD p < 0.0001 |
59 IMD 18 MM 114 IPM 12 PM 66 HC |
MM PM |
Children | Europe | Telleria-Orriols et al. [31] |
TIRAP rs8177374 | TIRAP rs8177374 ProIPD p = 0.003 | 191 IPD 741 HC |
IPD | Adults children |
UK | Khor and al [25] |
TLR2
rs5743708
TLR4 rs4986790 TLR4 rs4986791 |
no association |
99 IPD
178 HC |
IPD | – | Belgium | Moens et al. [28] |
TLR2 rs5743708 TLR4 rs4986790 TLR4 rs4986791 CD14-159CC FcγRIIA-R/R131 |
TLR4
rs4986790 ProPM p < 0.005 CD14-159CC SuIPD p < 0.05 FcγRIIA-R/R131 SuIPD p < 0.001 remaining SNPs —no association |
85 IPD 409 BD |
IPD | Children | Australia | Yuan and al [29] |
TLR2
TLR4 total nucleotide variation |
TLR2 rs57437708 more common in patients p = 0.05 | 197 IMD 238 HC |
IMD | Children | UK | Smirnova et al. [32] |
TLR2 rs5743708 TLR4 rs4986790 NOD1 rs6958571 NOD2 rs5743293 NOD2 rs2066847 NOD2 rs2066844 CASP1 rs2282659 |
TLR4
rs4986790 SuMM
NOD2 rs2066847 SuMM remaining SNPs —no association |
391 MM 82 PM 1141 HC |
MM PM |
Children | Netherlands | Van Wel et al. [36] |
TLR4 rs4986790 TLR4 rs4986791 | no association | 252 MM 251 HC |
MM | Children | Gambia | Allen et al. [35] |
TLR2 rs3804099 TLR3 rs3775291 TLR3 rs3775290 TLR9 rs352139 TLR9 rs352140 |
no association | 218 MB 330 HC |
BM | Children | China | Zhang et al. [38] |
Bold values indicate significant results
BD blood donors, BM bacterial meningitis, HC healthy controls, IPD invasive pneumococcal disease, IMD invasive meningococcal disease, MM meningococcal meningitis, PM pneumoccoccal meningitis, PB pneumoccoccal bacteraemia, SuPM susceptibility to pneumococcal meningitis, SuIPD susceptibility to invasive pneumococcal disease, SuIMD susceptibility to invasive meningococcal disease, SuMM susceptibility to meningococcal meningitis, ProIMD protection against invasive meningococcal disease, ProPM protection against pneumococcal meningitis